Abstract TH954: High, even more than low, ankle-brachial index (ABI) associated with elevated risk of incident cardiovascular disease and all-cause mortality: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

E Eyram Bansah (Johns Hopkins BSPH, Baltimore, Maryland, United States) Y Yejin Mok (Johns Hopkins University, Baltimore, Maryland, United States) P Pablo Martinez-Amezcua (Johns Hopkins University, Baltimore, Maryland, United States) Y Yumin Gao (Johns Hopkins BSPH, Baltimore, Maryland, United States) S Simin Hua (Albert Einstein College of Medicine, Bronx, New York, United States) M Maya Salameh (Johns Hopkins University, Baltimore, Maryland, United States) Q Qibin Qi J Jessica Williams-Nguyen (Fred Hutch Cancer Research Center, Seattle, Washington, United States) M Mollie Pester (University of Miami, Miami, Florida, United States) O Olga Garcia-Bedoya (University of Illinois at Chicago, Chicago, Illinois, United States) D Daniela Sotres-Alvarez M Martha Daviglus Y Yasmin Mossavar-Rahmani (Albert Einstein College of Medicine, Bronx, New York, United States) J Jennifer Schrack (Johns Hopkins University, Baltimore, Maryland, United States) M Matthew Allison R Robert Kaplan K Kunihiro Matsushita (Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).)

Abstract

Background: Low and high ankle-brachial index (ABI) values are associated with increased cardiovascular disease (CVD) risk, yet their prognostic value in Hispanics/Latinos has not been specifically studied, despite having unique vascular risk factor profiles compared to other races/ethnicities. Aim: We aimed to assess the prospective association of ABI with incident CVD and all-cause mortality in Hispanics/Latinos. Methods: We analyzed data from 8,000 adults (mean age 56, years; range, 45–74 years, 56% female) from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). The ABI was calculated from relevant extremity systolic blood pressures obtained at baseline (2008–2011) and modeled both continuously (cubic splines) and categorically (≤0.90, 0.91–1.00, 1.01–1.10 1.11–1.20 [reference], 1.21–1.30, and >1.30). Incident fatal and nonfatal CVD events (myocardial infarction, stroke, or heart failure) and all-cause mortality were assessed through 2021. Hazard ratios (HRs) were estimated using Cox models adjusting for confounders. We also conducted subgroup analysis by age, sex, smoking, diabetes, systolic blood pressure and kidney function. Results: Over a median follow-up of 11.6 years, there were 312 CVD events and 601 deaths. The average ABI was 1.08. High ABI (>1.30) vs. ABI 1.11–1.20 was significantly associated with an increased risk of incident CVD and all-cause mortality independently of potential confounders (HR 3.00, [95%CI: 1.40–6.44] and 2.70 [1.57–4.63], respectively). In contrast, low ABI (≤0.9) was significantly associated with all-cause mortality (HR 1.62 [1.04–2.54] but not with incident CVD. The results were largely similar when ABI was modeled continuously (Figure) with lowest risk at approximately ABI 1.10. The results were generally consistent across subgroups. Conclusion: High ABI was more strongly associated with mortality and incident CVD than low ABI in this Hispanic/Latino cohort. These findings have implications for interpreting ABI in this underrepresented population.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (17)

E

Eyram Bansah

Johns Hopkins BSPH, Baltimore, Maryland, United States

Y

Yejin Mok

Johns Hopkins University, Baltimore, Maryland, United States

P

Pablo Martinez-Amezcua

Johns Hopkins University, Baltimore, Maryland, United States

Y

Yumin Gao

Johns Hopkins BSPH, Baltimore, Maryland, United States

S

Simin Hua

Albert Einstein College of Medicine, Bronx, New York, United States

M

Maya Salameh

Johns Hopkins University, Baltimore, Maryland, United States

Q

Qibin Qi

J

Jessica Williams-Nguyen

Fred Hutch Cancer Research Center, Seattle, Washington, United States

M

Mollie Pester

University of Miami, Miami, Florida, United States

O

Olga Garcia-Bedoya

University of Illinois at Chicago, Chicago, Illinois, United States

D

Daniela Sotres-Alvarez

M

Martha Daviglus

Y

Yasmin Mossavar-Rahmani

Albert Einstein College of Medicine, Bronx, New York, United States

J

Jennifer Schrack

Johns Hopkins University, Baltimore, Maryland, United States

M

Matthew Allison

R

Robert Kaplan

K

Kunihiro Matsushita

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.M.).